Future Trends in Refractive Surgery

Future Trends in Refractive Surgery

Future Trends in Refractive Surgery

On this page

Next-Gen LVC - Laser Sharp Futures

  • Femtosecond Laser Advancements:
    • Higher frequency (> 1 MHz), lower energy systems: Smoother cuts, reduced inflammation, faster recovery.
    • Robotic assistance: Enhanced precision, improved docking, and surgical consistency.
  • Novel Ablation Profiles & Techniques:
    • SILK (Smooth Incision Lenticule Keratomileusis): Advanced lenticule extraction.
    • CAIRS (Corneal Allogenic Intrastromal Ring Segments): For keratoconus management.
    • Sophisticated topography-guided ablations & presbyopia-correcting profiles (e.g., PresbyMAX).
  • AI Integration in LVC:
    • Pre-op: AI-driven personalized nomograms, advanced risk stratification.
    • Intra-op: AI for real-time eye tracking, cyclotorsion compensation.
    • Post-op: AI for predictive modeling of outcomes. SMILE procedure steps

⭐ SILK (Smooth Incision Lenticule Keratomileusis) by J&J Vision aims for improved outcomes by creating biconvex lenticules and smoother stromal beds, potentially offering quicker visual recovery.

Advanced Lens Solutions - Intelligent Lens Innovations

  • Extended Depth of Focus (EDOF) IOLs:
    • Provide a continuous range of vision, reducing spectacle dependence.
    • Work by creating a single elongated focal point, unlike multifocal distinct points.
    • May have fewer halos/glare issues compared to older multifocal IOLs.
  • Trifocal IOLs:
    • Offer clear vision at near, intermediate, and distant focal points.
    • Aim to provide greater spectacle independence.
  • Accommodating IOLs (AIOLs):
    • Designed to mimic the eye's natural accommodation by changing focus.
    • Mechanisms: axial movement, shape change, or refractive index shift.
    • Current generation offers limited but improving accommodative amplitude.
  • Phakic IOLs Evolution:
    • Improved materials (e.g., collamer) and designs (e.g., central port for aqueous flow - reduces cataract/glaucoma risk).
    • Wider range of dioptric correction.
  • Minimally Invasive Techniques:
    • Preloaded IOL injectors for smaller incisions.
    • Femtosecond laser-assisted lens surgery for precision.

Trifocal GP IOL light path, through-focusing, and MTF

Light Adjustable Lens (LAL): Allows non-invasive, post-operative refinement of sphere, cylinder, and EDOF profile using UV light, offering precise visual outcomes. This is a significant advancement in customizable vision correction after cataract surgery or refractive lens exchange (RLE).

Corneal Biomechanics & Regeneration - Cornea's Comeback Crew

  • Corneal Biomechanics: Assesses corneal strength (CH, CRF); vital for ectasia risk.
  • Advanced Cross-Linking (CXL): Halts ectasia. Standard (Dresden): 3 $mW/cm^2$, 30min.
    • Epi-on CXL: Transepithelial, ↓pain, faster recovery.
    • Accelerated CXL: ↑UVA (e.g., 9 $mW/cm^2$, 10min), ↓duration.
    • CXL Xtra/Plus: CXL with PRK/ICRS.
  • Expanded CXL Horizons:
    • Thin Corneas (<400 $\mu m$): With hypo-osmolar riboflavin.
    • Infectious Keratitis (IK): Pack-CXL as adjunct therapy.
  • Corneal Regeneration:
    • Endothelial Cell Therapy: Cultured cells for endothelial dysfunction.
    • Bioengineered Corneas: Stromal analogues, 3D bioprinting.
    • Lenticule Re-implantation: SMILE lenticules for hyperopia/aphakia. 📌 ReLACS Diagram of CXL techniques

⭐ Corneal Allogenic Intrastromal Ring Segments (CAIRS) using donor cornea are emerging for keratoconus, offering better biocompatibility than synthetic ICRS.

Pharmacological & Novel Approaches - Drug & Gene Dreams

  • Presbyopia Eye Drops:
    • Miotics (e.g., Pilocarpine HCl 1.25% - Vuity): ↑ depth of focus via miosis.
    • Lens softening agents (experimental): Aim to restore accommodation.
  • Pharmacological Myopia Control:
    • Low-dose Atropine (0.01% - 0.05%): Most effective, slows progression. Mechanism: non-accommodative, acts on scleral/retinal receptors.
    • Pirenzepine (M1 antagonist), 7-Methylxanthine (adenosine antagonist) - less common.
  • Gene Therapy (Investigational):
    • Targets: Scleral remodeling genes (e.g., collagen, MMPs), growth factors (e.g., TGF-β).
    • Goal: Modulate eye growth, scleral biomechanics to prevent/correct myopia.
    • Vectors: Adeno-Associated Virus (AAV) commonly explored.

⭐ Low-dose atropine (0.01%) is a widely recognized pharmacological intervention for effectively slowing myopia progression in children, with minimal side effects compared to higher concentrations.

High‑Yield Points - ⚡ Biggest Takeaways

  • Lenticule extraction advancements like SMILE Pro & CLEAR promise faster, wider applications.
  • Highly personalized ablations using topography-guided & wavefront-optimized techniques are increasing.
  • Novel presbyopia solutions include advanced corneal inlays, presbyLASIK, and scleral procedures.
  • Light Adjustable IOLs (LAL) offer precise, non-invasive post-operative refractive adjustment.
  • Pharmacological myopia control (e.g., low-dose atropine) and CXL alternatives are key research areas.
  • Artificial Intelligence (AI) is enhancing patient selection, surgical planning, and outcome prediction.

Practice Questions: Future Trends in Refractive Surgery

Test your understanding with these related questions

Which of the following is the optimal position for inserting an IOL during a cataract surgery?

1 of 5

Flashcards: Future Trends in Refractive Surgery

1/9

Hyperopic photorefractive keratotomy is used for treatment of _____

TAP TO REVEAL ANSWER

Hyperopic photorefractive keratotomy is used for treatment of _____

hypermetropia (hypermetropia/myopia)

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial